Radioactive iodine treatment for differentiated thyroid carcinoma in Japan

Surgery

Volumn 147, Issue 3, 2010, Pages 432-433

  Okamoto, Takahiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

EDITORIAL; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; JAPAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; REIMBURSEMENT; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

CARCINOMA; HUMANS; IODINE RADIOISOTOPES; JAPAN; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 76749133084     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.11.007     Document Type: Editorial

References (10)

1. Sawka A.M., Brierley J.D., Tsang R.W., Thabane L., Rotstein L., Gafni A., et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 37 (2008) 457-480
2. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142. http://www.thyroid.org/professionals/publications/documents/guidelinesthy2006.pdf Available from
3. British Thyroid Associations & Royal College of Physicians. Guidelines for the management of thyroid cancer in adults. 2nd ed. 2007. Available from: www.british-thyroid-association.org
4. NCCN Clinical Practice Guidelines in Oncology. Thyroid Carcinoma (2009 v1). Available from: http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf
5. Tuttle R.M., Leboeuf R., and Shaha A.R. Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol 97 (2008) 712-716
6. Hundahl S.A., Cady B., Cunningham M.P., Mazzaferri E., McKee R.F., Rosai J., et al., Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89 (2000) 202-217
7. Udelsman R., and Shaha A.R. Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?. Lancet Oncol 6 (2005) 529-531
8. Orita Y., Sugitani I., Matsuura M., Ushijima M., Tsukahara K., and Fujimoto Y. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 147 (2010) 424-431
9. Shigematsu N., Takami H., Ito N., and Kubo A. Nationwide survey on the treatment policy for well-differentiated thyroid cancer - results of a questionnaire distributed at the 37th meeting of the Japanese Society of Thyroid Surgery. Endocr J 52 (2005) 479-491
10. Sugitani I., Kasai N., Fujimoto Y., and Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during follow-up period. Surgery 135 (2004) 139-148